CannaPharmaRx Inc (CPMD) stock news · rev $276.2K
CannaPharmaRx Inc (CPMD) is a drug manufacturers - specialty & generic company listed on US.
This CPMD news page leads with what CannaPharmaRx Inc filed — not a scraped headline mill.
No cached 8-K sentence for CPMD yet. We will not pad this page with generic market recap.
Latest reported CPMD revenue for 2026-06-30 was $276.2K. Net income was -$1.9M. Revenue was down 56.0% from 2026-03-31 to 2026-06-30. CPMD currently screens at market cap $1.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CPMD stock page; for the tape open the quote page.
Not investment advice.